News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
856,701 Results
Type
Article (87141)
Company Profile (704)
Press Release (768835)
Multimedia
Podcasts (160)
Webinars (24)
Section
Business (232941)
Career Advice (4136)
Deals (39774)
Drug Delivery (132)
Drug Development (91169)
Employer Resources (200)
FDA (18233)
Job Trends (17382)
News (397108)
Policy (39876)
Tag
Academia (3002)
Academic (2)
Accelerated approval (16)
Adcomms (33)
Allergies (111)
Alliances (56979)
ALS (129)
Alzheimer's disease (1630)
Antibody-drug conjugate (ADC) (197)
Approvals (18214)
Artificial intelligence (438)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (143)
Biotechnology (482)
Bladder cancer (111)
Brain cancer (45)
Breast cancer (425)
Cancer (3389)
Cardiovascular disease (274)
Career advice (3548)
Career pathing (34)
CAR-T (224)
CDC (43)
Cell therapy (614)
Cervical cancer (27)
Clinical research (74718)
Collaboration (1219)
Company closure (4)
Compensation (807)
Complete response letters (44)
COVID-19 (2929)
CRISPR (72)
C-suite (450)
Cystic fibrosis (128)
Data (3463)
Decentralized trials (2)
Denatured (57)
Depression (89)
Diabetes (397)
Diagnostics (7026)
Digital health (28)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (202)
Drug pricing (168)
Drug shortages (36)
Duchenne muscular dystrophy (175)
Earnings (98600)
Editorial (52)
Employer branding (25)
Employer resources (169)
Events (132079)
Executive appointments (941)
FDA (20372)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1087)
Gene editing (155)
Generative AI (43)
Gene therapy (483)
GLP-1 (977)
Government (5329)
Grass and pollen (7)
Guidances (328)
Healthcare (20933)
HIV (47)
Huntington's disease (32)
IgA nephropathy (50)
Immunology and inflammation (202)
Immuno-oncology (17)
Indications (44)
Infectious disease (3139)
Inflammatory bowel disease (173)
Inflation Reduction Act (13)
Influenza (83)
Intellectual property (150)
Interviews (814)
IPO (17916)
IRA (59)
Job creations (5195)
Job search strategy (2863)
Kidney cancer (15)
Labor market (66)
Layoffs (617)
Leadership (30)
Legal (10143)
Liver cancer (88)
Longevity (12)
Lung cancer (474)
Lymphoma (243)
Machine learning (17)
Management (65)
Manufacturing (523)
MASH (113)
Medical device (14798)
Medtech (14811)
Mergers & acquisitions (22651)
Metabolic disorders (1026)
Multiple sclerosis (109)
NASH (23)
Neurodegenerative disease (171)
Neuropsychiatric disorders (49)
Neuroscience (2473)
NextGen: Class of 2025 (7687)
Non-profit (5094)
Now hiring (54)
Obesity (519)
Opinion (300)
Ovarian cancer (110)
Pain (140)
Pancreatic cancer (139)
Parkinson's disease (210)
Partnered (27)
Patents (368)
Patient recruitment (231)
Peanut (55)
People (65943)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23044)
Phase II (32435)
Phase III (24431)
Pipeline (2346)
Policy (273)
Postmarket research (3554)
Preclinical (10403)
Press Release (72)
Prostate cancer (165)
Psychedelics (48)
Radiopharmaceuticals (279)
Rare diseases (579)
Real estate (7404)
Recruiting (76)
Regulatory (27543)
Reports (64)
Research institute (2668)
Resumes & cover letters (650)
Rett syndrome (11)
RNA editing (14)
RSV (62)
Schizophrenia (113)
Series A (180)
Series B (130)
Service/supplier (30)
Sickle cell disease (73)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4313)
State (2)
Stomach cancer (17)
Supply chain (89)
Tariffs (81)
The Weekly (101)
Vaccines (984)
Venture capital (63)
Weight loss (358)
Women's health (54)
Worklife (20)
Date
Today (127)
Last 7 days (593)
Last 30 days (2766)
Last 365 days (34094)
2025 (22240)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (75)
Alaska (7)
Arizona (290)
Arkansas (14)
Asia (50719)
Australia (8909)
California (8590)
Canada (2620)
China (801)
Colorado (365)
Connecticut (385)
Delaware (234)
Europe (116439)
Florida (1281)
Georgia (295)
Hawaii (3)
Idaho (67)
Illinois (775)
India (42)
Indiana (419)
Iowa (19)
Japan (255)
Kansas (120)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1188)
Massachusetts (6521)
Michigan (290)
Minnesota (529)
Mississippi (4)
Missouri (111)
Montana (32)
Nebraska (26)
Nevada (96)
New Hampshire (75)
New Jersey (2374)
New Mexico (31)
New York (2353)
North Carolina (1326)
North Dakota (10)
Northern California (3793)
Ohio (272)
Oklahoma (17)
Oregon (49)
Pennsylvania (1818)
Puerto Rico (18)
Rhode Island (42)
South America (1654)
South Carolina (43)
South Dakota (1)
Southern California (3237)
Tennessee (138)
Texas (1347)
United States (32094)
Utah (256)
Virginia (233)
Washington D.C. (82)
Washington State (740)
West Virginia (4)
Wisconsin (90)
There are 856,701 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoff Tracker
Exelixis Cuts Go Beyond Pennsylvania, Include 71 at California HQ
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
August 29, 2025
·
194 min read
·
BioSpace Editorial Staff
Policy
Kennedy Promised Medical Freedom. New COVID-19 Vaccine Restrictions Provide the Opposite
During the COVID-19 pandemic, Health Secretary Robert F. Kennedy Jr.—along with FDA Commissioner Marty Makary and CBER Director Vinay Prasad—argued against vaccine mandates, partly because they limited medical choice. This week, the FDA under their leadership approved updated COVID-19 vaccines with restrictions that do the same.
August 29, 2025
·
5 min read
·
Heather McKenzie
Obesity
Teva Brings First GLP-1 Generic for Obesity, Targets Novo’s Saxenda
In December 2024, Teva also secured FDA approval for the other liraglutide brand Victoza, indicated for type 2 diabetes.
August 29, 2025
·
2 min read
·
Tristan Manalac
Press Releases
MustGrow Closes Non-Brokered LIFE Offering of Approximately $2.1 Million, Repricing of Warrants, and Shares for Debt Settlement
August 29, 2025
·
8 min read
Government
Senate Summons Kennedy Again Amid CDC Leadership Turmoil
Health Secretary Robert F. Kennedy Jr. will testify before the Senate Finance Committee on Sept. 4, following the ouster of CDC Director Susan Monarez and tapping of HHS Deputy Secretary Jim O’Neill as her interim replacement.
August 29, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Nanotechnology Market Size Expected to Hit USD 116.39 Billion by 2034
August 29, 2025
·
1 min read
Press Releases
BGI-Research Publishes Stereo-Seq V2: Unlocking High-Resolution, In Situ Host–Microbe Transcriptome Mapping On FFPE Samples
August 29, 2025
·
1 min read
Immunology and inflammation
J&J Ends Rheumatoid Arthritis Program After Disappointing Mid-Stage Data
Nipocalimab, approved as Imaavy for generalized myasthenia gravis earlier this year, failed to show significantly added benefit when used with an anti-TNFα therapy in patients with rheumatoid arthritis.
August 29, 2025
·
2 min read
·
Tristan Manalac
Press Releases
United Therapeutics Corporation to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
August 29, 2025
·
2 min read
Press Releases
Bristol Myers Squibb to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
August 29, 2025
·
1 min read
1 of 85,671
Next
